Tag: metastatic

Despite advancements in cancer detection and treatment, breast cancer that comes back or spreads still presents a challenge to researchers ...

Cancer spreads via circulating tumor cells (CTCs) that travel through the blood to other organs, and they are nearly impossible ...

Talin is a protein that controls cellular attachment and movement, but its malfunctioning also allows cancer cells to spread. DCL1 ...

NEW YORK, NY (June 27, 2022)--More than 62,000 people in the United States will be diagnosed with pancreatic cancer by the end ...

Breast cancers with HER2 mutations respond to the drug neratinib, but the responses are variable and often not durable. Looking ...

FOR IMMEDIATE RELEASE Spreading cancer cells that escape a primary tumor site can seed in tissues distant from the tumor, ...

Researchers at the University of Oklahoma are testing an experimental treatment for metastatic cancer focusing on pancreatic cancer. Metastasis, the ...

Philadelphia, April 13, 2022 – Researchers have found that treating prostate cancer cells with novel cyclin-dependent kinase 19 (CDK19) and ...

A novel nuclear medicine combination therapy has been proven safe and effective in men with heavily pre-treated metastatic castration-resistant prostate ...

Rac and Cdc42* are well-studied low molecular weight G proteins that regulate the ability of cancer cells to move, which ...

LOS ANGELES — A new study from Keck Medicine of USC finds that the incidence rate of metastatic prostate cancer ...

A study led by researchers from The University of Texas MD Anderson Cancer Center showed a significant overall survival benefit ...

Reston, VA—A novel prostate cancer treatment—225Ac-PSMA-617 radioligand therapy—has been shown to increase the progression free survival (PFS) and overall survival ...

LOS ANGELES and MOUNTAIN VIEW, Calif. — City of Hope, one of the largest cancer research and treatment organizations in ...

  Credit: Vall d'Hebron Institute of Oncology (VHIO). VHIO-led research published in Cancer Research Communications shows that the first-in-class MYC ...

CAMBRIDGE, Mass., February 18, 2022 — Codiak BioSciences, Inc. (NASDAQ: CDAK), a clinical-stage biopharmaceutical company pioneering the development of exosome-based ...

BOSTON – Results from an international, randomized, double-blind, placebo-controlled, phase 3 clinical trial indicate that adding the androgen-receptor inhibitor darolutamide to androgen-deprivation ...

An experimental form of immunotherapy that uses an individual’s own tumor-fighting immune cells could potentially be used to treat people ...

What The Study Did: This study investigated how common the use of extended radiation therapy is to treat metastatic cancer ...

Metabolic differences could explain why some metastatic breast cancer cells rapidly generate tumors after migrating from primary tumors to the ...